SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic decline today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending its stock price plummeting by over fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate